Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ARROWHEAD PHRMCT RG (NQ: ARWR)
6.950 USD  -0.060 (-0.86%)
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 659,602
Open 6.980
Bid (Size) 6.390 (1000)
Ask (Size) 7.050 (300)
Prev. Close 7.010
Today's Range 6.850 - 7.089
52wk Range 1.420 - 8.090
Shares Outstanding 86,787,566
Dividend Yield N/A
Performance
YTD
+86.83%
+86.83%
1 Month
-3.34%
-3.34%
3 Month
+21.50%
+21.50%
6 Month
+73.75%
+73.75%
1 Year
+360.26%
+360.26%
Top News
More News
Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™
Arrowhead Pharmaceuticals presents data on ARC-520 at EASL 2018 Read More
from Business Wire News Releases
Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™
Arrowhead Pharma will present data at EASL International Liver Congress 2018 Read More
from Business Wire News Releases
More News
Read More
Markets soar as bond yields slide
category Market News
from MarketMinute.com Market Updates
Arrowhead Pharmaceuticals extends gains
from MarketMinute.com Stock News
Detailed Research: Economic Perspectives on Etsy, Tiffany, First BanCorp, Deere, Callaway Golf, and Arrowhead Pharmaceuticals — What Drives Growth in Today's Competitive Landscape
from GlobeNewswire News Releases
Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
from Business Wire News Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
from Business Wire News Releases
Arrowhead Begins Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
from Business Wire News Releases
Arrowhead to Present at Barclays Global Healthcare Conference 2018
from Business Wire News Releases
Arrowhead Pharma Up 15.6% Since SmarTrend Uptrend Call (ARWR)
from Comtex SmarTrend® News Briefs
Arrowhead Pharma Rising on Above-Average Volume, Consistent With Trend (ARWR)
from Comtex SmarTrend® News Briefs
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
X